MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ... Focus 21 (3), 315-328, 2023 | 640 | 2023 |
The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early … JD Woolley, BK Khan, NK Murthy, BL Miller, KP Rankin The Journal of clinical psychiatry 72 (2), 4437, 2011 | 530 | 2011 |
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia JD Woolley, ML Gorno-Tempini, WW Seeley, K Rankin, SS Lee, ... Neurology 69 (14), 1424-1433, 2007 | 293 | 2007 |
Cognitive and behavioral profile in a case of right anterior temporal lobe neurodegeneration ML Gorno-Tempini, KP Rankin, JD Woolley, HJ Rosen, L Phengrasamy, ... Cortex 40 (4-5), 631-644, 2004 | 202 | 2004 |
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study BT Anderson, A Danforth, R Daroff, C Stauffer, E Ekman, G Agin-Liebes, ... EClinicalMedicine 27, 2020 | 165 | 2020 |
Oxytocin administration enhances controlled social cognition in patients with schizophrenia JD Woolley, B Chuang, O Lam, W Lai, A O’Donovan, KP Rankin, ... Psychoneuroendocrinology 47, 116-125, 2014 | 130 | 2014 |
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials JS Aday, BD Heifets, SD Pratscher, E Bradley, R Rosen, JD Woolley Psychopharmacology 239 (6), 1989-2010, 2022 | 116 | 2022 |
Psychedelic-assisted group therapy: a systematic review A Trope, BT Anderson, AR Hooker, G Glick, C Stauffer, JD Woolley Journal of psychoactive drugs 51 (2), 174-188, 2019 | 104 | 2019 |
Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ... Jama 330 (9), 843-853, 2023 | 102 | 2023 |
Intranasal oxytocin selectively modulates social perception, craving, and approach behavior in subjects with alcohol use disorder JM Mitchell, PA Arcuni, D Weinstein, JD Woolley Journal of addiction medicine 10 (3), 182-189, 2016 | 92 | 2016 |
Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward ER Bradley, JD Woolley Neuroscience & Biobehavioral Reviews 80, 36-56, 2017 | 87 | 2017 |
Nucleus accumbens opioids regulate flavor-based preferences in food consumption JD Woolley, BS Lee, HL Fields Neuroscience 143 (1), 309-317, 2006 | 83 | 2006 |
Intranasal oxytocin may improve high-level social cognition in schizophrenia, but not social cognition or neurocognition in general: a multilevel bayesian meta-analysis PC Bürkner, DR Williams, TC Simmons, JD Woolley Schizophrenia Bulletin 43 (6), 1291-1303, 2017 | 80 | 2017 |
Frontotemporal dementia and mania JD Woolley, MR Wilson, E Hung, ML Gorno-Tempini, BL Miller, J Shim American Journal of Psychiatry 164 (12), 1811-1816, 2007 | 79 | 2007 |
Intranasal oxytocin mechanisms can be better understood, but its effects on social cognition and behavior are not to be sniffed at DS Quintana, JD Woolley Biol Psychiatry 79 (8), e49-e50, 2016 | 60 | 2016 |
Endogenous dopaminergic modulation of the lamprey spinal locomotor network E Svensson, J Woolley, M Wikström, S Grillner Brain research 970 (1-2), 1-8, 2003 | 58 | 2003 |
A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder CS Stauffer, V Musinipally, A Suen, KL Lynch, B Shapiro, JD Woolley Addiction research & theory 24 (6), 490-498, 2016 | 56 | 2016 |
Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report. M Fisher, M Nahum, E Howard, A Rowlands, B Brandrett, A Kermott, ... Psychiatric rehabilitation journal 40 (1), 21, 2017 | 54 | 2017 |
Endogenous opioids encode relative taste preference SA Taha, E Norsted, LS Lee, PD Lang, BS Lee, JD Woolley, HL Fields European Journal of Neuroscience 24 (4), 1220-1226, 2006 | 52 | 2006 |
Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience CS Stauffer, BT Anderson, KM Ortigo, J Woolley ACS pharmacology & translational science 4 (2), 526-532, 2020 | 49 | 2020 |